Novel endometrial receptivity test increases clinical pregnancy and live birth rates in patients with recurrent implantation failure: Secondary analysis of a prospective clinical trial
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70157 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Yu Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Embryo Implantation, Endometrium, Embryo Transfer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing health promotion association research fund for young fertility doctors.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the efficiency of endometrial receptivity testing (ERT) in improving pregnancy outcomes for patients with recurrent implantation failure (RIF), and to investigate the incidence of implantation window displacement.
Methods
Conducted between April 2021 and August 2022, at a university‐affiliated reproductive center, the study included 85 RIF patients who had failed to achieve pregnancy after three embryo transfers. As part of a multicenter prospective cohort study (ChiCTR2200059342), 45 patients underwent ERT‐guided frozen single blastocyst transfer, while 40 received standard treatment without ERT. Endometrial preparation was performed using a hormone replacement therapy (HRT) protocol in the cycle preceding transfer. Endometrial sampling for ERT, including RNA sequencing, artificial intelligence, and discriminant analysis of endometrial receptivity, was conducted on day 5 after progesterone administration to determine the implantation window. The same HRT protocol was used in the transfer cycle, with embryo transfer timed according to the ERT‐calculated window.
Results
Our data showed that 28.07% of patients exhibited a displaced implantation window, all characterized by pre‐receptive endometrium. The ERT group had significantly higher clinical pregnancy rates (57.78% vs. 35.00%, p = 0.036) and live birth rates (53.33% vs. 30.00%, p = 0.030) compared with the non‐ERT group.
Conclusion
Our findings suggest that approximately one‐third of RIF occurrences may be due to endometrial factors, and ERT‐guided personalized embryo transfer significantly improves pregnancy outcomes, underscoring its value in reproductive medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Xiyuan Dong
Förderung
- National Key Research and Development Program of China
- Beijing health promotion association research fund for young fertility doctors
Zitieren
APA
Zheng, Y., Xu, N., Chen, B., Dai, J., Bai, J., Huang, B., Jin, L., Dong, X., & Li, Z. (2025). Novel endometrial receptivity test increases clinical pregnancy and live birth rates in patients with recurrent implantation failure: Secondary analysis of a prospective clinical trial. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70157
Vancouver
Zheng Y, Xu N, Chen B, Dai J, Bai J, Huang B, et al. Novel endometrial receptivity test increases clinical pregnancy and live birth rates in patients with recurrent implantation failure: Secondary analysis of a prospective clinical trial. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70157
BibTeX
@article{Zheng2025,
author = {Zheng, Yu and Xu, Na and Chen, Biao and Dai, Jun and Bai, Jian and Huang, Bo and Jin, Lei and Dong, Xiyuan and Li, Zhou},
title = {Novel endometrial receptivity test increases clinical pregnancy and live birth rates in patients with recurrent implantation failure: Secondary analysis of a prospective clinical trial},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70157}
}
EUVIMED